UCB PHARMA SA
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Public, Subsidiary
- Established
- 1928-01-01
- Employees
- 9K
- Market Cap
- $34.9B
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 295
- Registration Number
- NCT00498186
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- UCB Pharma SA
- Target Recruit Count
- 399
- Registration Number
- NCT00490035
- Locations
- 🇫🇷
52, Montpellier Cedex, France
🇩🇪71, Ulm, Germany
🇭🇺94, Budapest, Hungary
Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee
- First Posted Date
- 2007-06-13
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 194
- Registration Number
- NCT00485472
Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
- First Posted Date
- 2007-06-11
- Last Posted Date
- 2011-09-12
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 232
- Registration Number
- NCT00484536
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 287
- Registration Number
- NCT00474058
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
- First Posted Date
- 2007-04-24
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 230
- Registration Number
- NCT00464737
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Phase 3
Completed
- Conditions
- Epilepsy
- Interventions
- First Posted Date
- 2007-04-23
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 400
- Registration Number
- NCT00464269
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Completed
- Conditions
- Allergies
- First Posted Date
- 2007-03-29
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 4581
- Registration Number
- NCT00453583
- Locations
- 🇺🇸
UCB Pharma, Smyrna, Georgia, United States
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
- First Posted Date
- 2007-02-27
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 218
- Registration Number
- NCT00440518
An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.
Phase 1
Completed
- Conditions
- Epilepsy
- First Posted Date
- 2007-01-25
- Last Posted Date
- 2008-03-10
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 15
- Registration Number
- NCT00426673
© Copyright 2025. All Rights Reserved by MedPath